Companies: 10,795·Total market cap: $144.5T
Timber Pharmaceuticals, Inc.

Timber Pharmaceuticals, Inc.

TMBRAMEXHealthcare
$0.34
+$0.00(+0.74%)
Market Cap$1176057
P/E Ratio
52W High$3.39
52W Low$0.32
Overview

Timber Pharmaceuticals, Inc.(TMBR)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · TMBR · 截至 Jun 9, 2026

关键指标

EPS (TTM)tmbr eps ttm · tmbr earnings per shareEarnings history
PE Ratio (TTM)tmbr pe ratio ttm · tmbr price to earningsPE Ratio deep dive
Revenue (TTM)tmbr revenue ttm · tmbr annual revenueFull revenue history
Dividend Yield不分红does tmbr pay dividends · tmbr dividend yieldDividend history
Shares Outstandingtmbr shares outstanding · tmbr floatShares outstanding history
Next EarningsTBAtmbr earnings date · tmbr next earningsEarnings history

分析师评级与目标价

完整预测
SellBuy
Hold1 位分析师is tmbr a buy · tmbr analyst rating
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.34Current
$Avg Target
$High
tmbr price target · tmbr 12 month forecast

合计: 1 · 买入占比: 0.0%

关于 Timber Pharmaceuticals, Inc.

CEOJohn Koconis
IPO DateSep 8, 2014
Employees9
CountryUS

Timber Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the research, development, and market introduction of treatments for rare dermatological conditions…

what is timber pharmaceuticals, inc. · tmbr stock overview · timber pharmaceuticals, inc. company profile · who is timber pharmaceuticals, inc. ceo · tmbr AMEX · timber pharmaceuticals, inc. headquarters · timber pharmaceuticals, inc. business segments

关于股票概览与关键数据

Timber Pharmaceuticals, Inc.(TMBR)是 Biotechnology 行业的 Healthcare 类公司,于 Sep 8, 2014 在 AMEX 上市。截至最近交易日,TMBR 股价为 $0.34,市值约为 $1.2M。过去12个月累计回报 —,年初至今回报 —。

常见问题

截至最近一个交易日,Timber Pharmaceuticals, Inc.(TMBR)股价为 $0.34,在 AMEX 上市,52周区间为 $0.32 – $3.39。

TMBR 最新股价TMBR quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议